These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36681663)

  • 1. Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer.
    Su YH; Wu YZ; Ann DK; Chen JL; Kuo CY
    Cell Death Dis; 2023 Jan; 14(1):53. PubMed ID: 36681663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells.
    Khozooei S; Lettau K; Barletta F; Jost T; Rebholz S; Veerappan S; Franz-Wachtel M; Macek B; Iliakis G; Distel LV; Zips D; Toulany M
    J Exp Clin Cancer Res; 2022 Aug; 41(1):256. PubMed ID: 35989353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer.
    Sriramulu S; Thoidingjam S; Chen WM; Hassan O; Siddiqui F; Brown SL; Movsas B; Green MD; Davis AJ; Speers C; Walker E; Nyati S
    J Exp Clin Cancer Res; 2024 Jun; 43(1):163. PubMed ID: 38863037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types.
    Dinkelborg PH; Wang M; Gheorghiu L; Gurski JM; Hong TS; Benes CH; Juric D; Jimenez RB; Borgmann K; Willers H
    Breast Cancer Res Treat; 2019 Apr; 174(3):605-613. PubMed ID: 30607635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
    Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
    Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of SERPINE1 reverses resistance of triple‑negative breast cancer to paclitaxel via suppression of VEGFA.
    Zhang Q; Lei L; Jing D
    Oncol Rep; 2020 Nov; 44(5):1875-1884. PubMed ID: 33000256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer.
    Tu X; Kahila MM; Zhou Q; Yu J; Kalari KR; Wang L; Harmsen WS; Yuan J; Boughey JC; Goetz MP; Sarkaria JN; Lou Z; Mutter RW
    Mol Cancer Ther; 2018 Nov; 17(11):2462-2472. PubMed ID: 30166399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody.
    Song H; Hedayati M; Hobbs RF; Shao C; Bruchertseifer F; Morgenstern A; Deweese TL; Sgouros G
    Mol Cancer Ther; 2013 Oct; 12(10):2043-54. PubMed ID: 23873849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer.
    Bai X; Ni J; Beretov J; Wang S; Dong X; Graham P; Li Y
    Adv Sci (Weinh); 2021 Dec; 8(24):e2102658. PubMed ID: 34708581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
    Ma Y; Zhang H; Chen C; Liu L; Ding T; Wang Y; Ma D; Ling X; Chen X; Li J; Guansheng ; Zhong ; Ru G; Zhang L; Tang J
    Oncogene; 2022 Mar; 41(11):1589-1599. PubMed ID: 35091679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.
    Wen Y; Dai G; Wang L; Fu K; Zuo S
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation.
    Zhang H; Zheng J; Fu Y; Ling J; Liu Z; Lin X; Dong X; Sun Y; Tan T; Guo Z; Xie G
    Breast Cancer Res Treat; 2023 Apr; 198(3):437-446. PubMed ID: 36797433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
    Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
    Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells.
    Michmerhuizen AR; Chandler B; Olsen E; Wilder-Romans K; Moubadder L; Liu M; Pesch AM; Zhang A; Ritter C; Ward ST; Santola A; Nyati S; Rae JM; Hayes D; Feng FY; Spratt D; Wahl D; Eisner J; Pierce LJ; Speers C
    Front Endocrinol (Lausanne); 2020; 11():35. PubMed ID: 32117061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
    Shao Z; Ma X; Zhang Y; Sun Y; Lv W; He K; Xia R; Wang P; Gao X
    Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer.
    Jabbour-Leung NA; Chen X; Bui T; Jiang Y; Yang D; Vijayaraghavan S; McArthur MJ; Hunt KK; Keyomarsi K
    Mol Cancer Ther; 2016 Apr; 15(4):593-607. PubMed ID: 26826118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-1290 modulates the radioresistance of triple-negative breast cancer by targeting NLRP3-mediated pyroptosis.
    Li Y; Li X
    Clin Transl Oncol; 2022 Sep; 24(9):1764-1775. PubMed ID: 35471684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer.
    Sriramulu S; Thoidingjam S; Chen WM; Hassan O; Siddiqui F; Brown SL; Movsas B; Green MD; Davis AJ; Speers C; Walker E; Nyati S
    bioRxiv; 2024 May; ():. PubMed ID: 38766122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Targeting of RSK and AKT Efficiently Inhibits YB-1-Mediated Repair of Ionizing Radiation-Induced DNA Double-Strand Breaks in Breast Cancer Cells.
    Lettau K; Zips D; Toulany M
    Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):567-580. PubMed ID: 32931865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.
    Zhang L; Bochkur Dratver M; Yazal T; Dong K; Nguyen A; Yu G; Dao A; Bochkur Dratver M; Duhachek-Muggy S; Bhat K; Alli C; Pajonk F; Vlashi E
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):195-207. PubMed ID: 30196056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.